Literature DB >> 33311477

AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion.

Anne Schuster1, Eliane Klein1, Virginie Neirinckx1, Arnon Møldrup Knudsen2,3, Carina Fabian1,4, Ann-Christin Hau1, Monika Dieterle1, Anais Oudin1, Petr V Nazarov5, Anna Golebiewska1, Arnaud Muller5, Daniel Perez-Hernandez5, Sophie Rodius5, Gunnar Dittmar5, Rolf Bjerkvig1,4, Christel Herold-Mende6, Barbara Klink7,8, Bjarne Winther Kristensen2,3, Simone P Niclou9,10.   

Abstract

The infiltrative nature of Glioblastoma (GBM), the most aggressive primary brain tumor, critically prevents complete surgical resection and masks tumor cells behind the blood brain barrier reducing the efficacy of systemic treatment. Here, we use a genome-wide interference screen to determine invasion-essential genes and identify the AN1/A20 zinc finger domain containing protein 3 (ZFAND3) as a crucial driver of GBM invasion. Using patient-derived cellular models, we show that loss of ZFAND3 hampers the invasive capacity of GBM, whereas ZFAND3 overexpression increases motility in cells that were initially not invasive. At the mechanistic level, we find that ZFAND3 activity requires nuclear localization and integral zinc-finger domains. Our findings indicate that ZFAND3 acts within a nuclear protein complex to activate gene transcription and regulates the promoter of invasion-related genes such as COL6A2, FN1, and NRCAM. Further investigation in ZFAND3 function in GBM and other invasive cancers is warranted.

Entities:  

Year:  2020        PMID: 33311477     DOI: 10.1038/s41467-020-20029-y

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  55 in total

1.  Myosin IIA suppresses glioblastoma development in a mechanically sensitive manner.

Authors:  Hannah S Picariello; Rajappa S Kenchappa; Vandana Rai; James F Crish; Athanassios Dovas; Katarzyna Pogoda; Mariah McMahon; Emily S Bell; Unnikrishnan Chandrasekharan; Amanda Luu; Rita West; Jan Lammerding; Peter Canoll; David J Odde; Paul A Janmey; Thomas Egelhoff; Steven S Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

Review 2.  RNAi/CRISPR Screens: from a Pool to a Valid Hit.

Authors:  Anne Schuster; Hélène Erasimus; Sabrina Fritah; Petr V Nazarov; Eric van Dyck; Simone P Niclou; Anna Golebiewska
Journal:  Trends Biotechnol       Date:  2018-08-31       Impact factor: 19.536

Review 3.  Glioblastoma quo vadis: Will migration and invasiveness reemerge as therapeutic targets?

Authors:  Florence Lefranc; Emilie Le Rhun; Robert Kiss; Michael Weller
Journal:  Cancer Treat Rev       Date:  2018-06-26       Impact factor: 12.111

Review 4.  An Experimenter's Guide to Glioblastoma Invasion Pathways.

Authors:  Mark C de Gooijer; Miriam Guillén Navarro; Rene Bernards; Thomas Wurdinger; Olaf van Tellingen
Journal:  Trends Mol Med       Date:  2018-07-30       Impact factor: 11.951

Review 5.  A neurocentric perspective on glioma invasion.

Authors:  Vishnu Anand Cuddapah; Stefanie Robel; Stacey Watkins; Harald Sontheimer
Journal:  Nat Rev Neurosci       Date:  2014-07       Impact factor: 34.870

6.  Brain tumour cells interconnect to a functional and resistant network.

Authors:  Matthias Osswald; Erik Jung; Felix Sahm; Gergely Solecki; Varun Venkataramani; Jonas Blaes; Sophie Weil; Heinz Horstmann; Benedikt Wiestler; Mustafa Syed; Lulu Huang; Miriam Ratliff; Kianush Karimian Jazi; Felix T Kurz; Torsten Schmenger; Dieter Lemke; Miriam Gömmel; Martin Pauli; Yunxiang Liao; Peter Häring; Stefan Pusch; Verena Herl; Christian Steinhäuser; Damir Krunic; Mostafa Jarahian; Hrvoje Miletic; Anna S Berghoff; Oliver Griesbeck; Georgios Kalamakis; Olga Garaschuk; Matthias Preusser; Samuel Weiss; Haikun Liu; Sabine Heiland; Michael Platten; Peter E Huber; Thomas Kuner; Andreas von Deimling; Wolfgang Wick; Frank Winkler
Journal:  Nature       Date:  2015-11-04       Impact factor: 49.962

7.  Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas.

Authors:  Sophie Weil; Matthias Osswald; Gergely Solecki; Julia Grosch; Erik Jung; Dieter Lemke; Miriam Ratliff; Daniel Hänggi; Wolfgang Wick; Frank Winkler
Journal:  Neuro Oncol       Date:  2017-10-01       Impact factor: 12.300

8.  RNAi-based functional selection identifies novel cell migration determinants dependent on PI3K and AKT pathways.

Authors:  Minchul Seo; Shinrye Lee; Jong-Heon Kim; Won-Ha Lee; Guang Hu; Stephen J Elledge; Kyoungho Suk
Journal:  Nat Commun       Date:  2014-10-28       Impact factor: 14.919

Review 9.  Diffuse glioma growth: a guerilla war.

Authors:  An Claes; Albert J Idema; Pieter Wesseling
Journal:  Acta Neuropathol       Date:  2007-09-06       Impact factor: 17.088

10.  Analysis of chromatin accessibility uncovers TEAD1 as a regulator of migration in human glioblastoma.

Authors:  Jessica Tome-Garcia; Parsa Erfani; German Nudelman; Alexander M Tsankov; Igor Katsyv; Rut Tejero; Martin Walsh; Roland H Friedel; Elena Zaslavsky; Nadejda M Tsankova
Journal:  Nat Commun       Date:  2018-10-01       Impact factor: 14.919

View more
  8 in total

1.  Hsa_circ_NOTCH3 regulates ZNF146 through sponge adsorption of miR-875-5p to promote tumorigenesis of hepatocellular carcinoma.

Authors:  Lei Bao; Min Wang; Qiqi Fan
Journal:  J Gastrointest Oncol       Date:  2021-10

Review 2.  Role of Tumor-Derived Extracellular Vesicles in Glioblastoma.

Authors:  Yunping Chen; Yan Jin; Nan Wu
Journal:  Cells       Date:  2021-02-28       Impact factor: 6.600

3.  Expression of Specific Alleles of Zinc-Finger Transcription Factors, HvSAP8 and HvSAP16, and Corresponding SNP Markers, Are Associated with Drought Tolerance in Barley Populations.

Authors:  Akmaral Baidyussen; Satyvaldy Jatayev; Gulmira Khassanova; Bekzak Amantayev; Grigory Sereda; Sergey Sereda; Narendra K Gupta; Sunita Gupta; Carly Schramm; Peter Anderson; Colin L D Jenkins; Kathleen L Soole; Peter Langridge; Yuri Shavrukov
Journal:  Int J Mol Sci       Date:  2021-11-10       Impact factor: 5.923

4.  TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas.

Authors:  Jiabo Li; Xuya Wang; Lulu Chen; Jinhao Zhang; Yiming Zhang; Xiao Ren; Jinzhang Sun; Xiaoguang Fan; Jikang Fan; Tao Li; Luqing Tong; Li Yi; Lei Chen; Jie Liu; Guanjie Shang; Xiude Ren; Hao Zhang; Shengping Yu; Haolang Ming; Qiang Huang; Jun Dong; Chen Zhang; Xuejun Yang
Journal:  Cancer Gene Ther       Date:  2022-01-06       Impact factor: 5.854

5.  The molecular, immune features, and risk score construction of intraductal papillary mucinous neoplasm patients.

Authors:  Xing Huang; Yipeng Feng; Dawei Ma; Hanlin Ding; Gaochao Dong; Yan Chen; Xiaochen Huang; Jingyuan Zhang; Xinyu Xu; Chen Chen
Journal:  Front Mol Biosci       Date:  2022-08-26

6.  Characterization and comparison of human glioblastoma models.

Authors:  Julia A Schulz; Louis T Rodgers; Richard J Kryscio; Anika M S Hartz; Björn Bauer
Journal:  BMC Cancer       Date:  2022-08-03       Impact factor: 4.638

7.  G-protein-coupled receptor GPR17 inhibits glioma development by increasing polycomb repressive complex 1-mediated ROS production.

Authors:  Huiqing Liu; Rui Xing; Zhimin Ou; Junying Zhao; Guolin Hong; Tong-Jin Zhao; Ying Han; Ying Chen
Journal:  Cell Death Dis       Date:  2021-06-12       Impact factor: 8.469

Review 8.  ADP-Ribosylation Post-Translational Modification: An Overview with a Focus on RNA Biology and New Pharmacological Perspectives.

Authors:  Giuseppe Manco; Giuseppina Lacerra; Elena Porzio; Giuliana Catara
Journal:  Biomolecules       Date:  2022-03-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.